tiprankstipranks
Vir has positive readthrough from Janux data, says Morgan Stanley
PremiumThe FlyVir has positive readthrough from Janux data, says Morgan Stanley
18d ago
Janux Therapeutics price target raised to $115 from $70 at Stifel
Premium
The Fly
Janux Therapeutics price target raised to $115 from $70 at Stifel
18d ago
Janux Therapeutics price target raised to $91 from $79 at Leerink
Premium
The Fly
Janux Therapeutics price target raised to $91 from $79 at Leerink
18d ago
Janux says emerging JANX007 data demonstrates ‘substantial clinical activity’
PremiumThe FlyJanux says emerging JANX007 data demonstrates ‘substantial clinical activity’
18d ago
Janux Therapeutics initiated with an Outperform at Leerink
Premium
The Fly
Janux Therapeutics initiated with an Outperform at Leerink
29d ago
Janux Therapeutics’ Q3 Report: Financials and Progress
Premium
Company Announcements
Janux Therapeutics’ Q3 Report: Financials and Progress
1M ago
Janux Therapeutics initiated with a Buy at UBS
PremiumThe FlyJanux Therapeutics initiated with a Buy at UBS
2M ago
Janux Therapeutics initiated with a Buy at Stifel
Premium
The Fly
Janux Therapeutics initiated with a Buy at Stifel
4M ago
Janux Therapeutics price target lowered to $42 from $47 at Scotiabank
Premium
The Fly
Janux Therapeutics price target lowered to $42 from $47 at Scotiabank
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100